Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.
BACKGROUND:The comparison between long acting insulin analogues (LAIA) and human insulin (NPH) has been investigated for decades, with many randomized controlled trials (RCTs) and systematic reviews giving mixed results. This overlapping and contradictory evidence has increased uncertainty on covera...
Main Authors: | Fernanda O Laranjeira, Keitty R C de Andrade, Ana C M G Figueiredo, Everton N Silva, Mauricio G Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5896894?pdf=render |
Similar Items
-
Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil.
by: Fernanda O Laranjeira, et al.
Published: (2016-01-01) -
Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine
by: E Warren, et al.
Published: (2004-11-01) -
Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
by: Karla F. S. Melo, et al.
Published: (2019-01-01) -
Insulin degludec is a new ultra-long-acting insulin analogue
by: Ivan Ivanovich Dedov, et al.
Published: (2014-06-01) -
POS-268 VITAMIN D ANALOGUES AND BONE OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
by: N. KHELIFI, et al.
Published: (2021-04-01)